Speaker: Prof. Thomas G. Martin (CA, USA)
Topic: High-risk diseases in multiple myeloma: R2-ISS and beyond
[su_youtube url=”https://youtu.be/_2ohrJKSbZk” width=”800″ height=”600″]
Speaker: Prof. Katja Weisel (Hamburg, Germany)
Topic: The evolving role of IMiD-based strategy for RRMM
[su_youtube url=”https://youtu.be/3RGaHgPZEzE” width=”800″ height=”600″]
Speaker: Dr. Elena Zamagni (Bologna, Italy)
Topic: Contemporary treatment paradigm of triple-class refractory multiple myeloma
[su_youtube url=”https://youtu.be/rx1Z1elZh1g” width=”800″ height=”600″]
Speaker: Dr. Rafael Fonseca (AZ, USA)
Topic: Optimizing treatment selection and sequencing for patients with RRMM
[su_youtube url=”https://youtu.be/Qw0ZhGBPmdU” width=”800″ height=”600″]
Speaker: Dr. Shambavi Richard (NY, USA)
Topic: Targeting XPO1 in relapsed/refractory multiple myeloma
[su_youtube url=”https://youtu.be/b5HXsRfH1IQ” width=”800″ height=”600″]